Global Local Anesthesia Drugs Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Local Anesthesia Drugs Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Local anesthetics produce anesthetic effects by suppressing the excitation of nerve endings or blocking the conduction of peripheral nerves. Local anesthesia is used to numb certain parts of the body. This will prevent pain during the procedure.

Market Overview:

The latest research study on the global Local Anesthesia Drugs market finds that the global Local Anesthesia Drugs market reached a value of USD 2337.6 million in 2022. It’s expected that the market will achieve USD 3799.28 million by 2028, exhibiting a CAGR of 8.43% during the forecast period.

Aging population

The global population is entering an aging phase. The number and proportion of older people is increasing in almost every country in the world. The elderly's body function declines, the stimulation of the external environment and the defense ability of disease-causing microorganisms are reduced, and they are more susceptible to chronic diseases, such as cardiovascular diseases and respiratory diseases, which are the main groups of medical resource consumption. Therefore, the aging of the population brings great opportunities for the development of the local anesthetic industry.

Growing health care spending in developing countries

With the development of the economy, the per capita disposable income has increased, and health concerns have gradually increased. More and more developing countries are spending more on health care. This means that more people can receive good treatment, which leads to an increase in the number of surgical procedures, which may increase the demand for local anesthetics.

More widely used

Local anesthetics are mainly used for ophthalmic anesthesia and analgesia. Compared to general anesthetics, local anesthetics are safer to use and have fewer side effects. Local anesthesia can be applied to the nose, eyes, skin, ears, mouth and other mucous membranes. As the number of surgical procedures continues to increase worldwide, the use of local anesthesia is becoming more widespread. In particular, the increase in the amount of dental and cosmetic surgery is rapidly promoting the development of the local anesthetic market. With the continuous development of medical technology, the use of local anesthetics has become increasingly common, especially in areas where medical technology is rapidly developing.

Region Overview:

In 2022, the share of the Local Anesthesia Drugs market in United States stood at 40.3%.

Company Overview:

Aspen Pharmacare is one of the major players operating in the Local Anesthesia Drugs market, holding a share of 23.63% in 2023.

Aspen Pharmacare

Aspen Pharmacare Holdings Limited operates as a holding company. The Company, through its subsidiaries, manufactures and supplies capsules, liquids, semi-solids, steriles, biologicals, pharmaceutical ingredients, and nutritionals for the treatment of acute and chronic conditions.

Gruenenthal

Gruenenthal Pharma GmbH & Co. Kommanditgesellschaft operates as a pharmaceutical company. The Company produces, fabricates, and processes drugs in pharmaceutical preparations for human and veterinary use.

Segmentation Overview:

Among different product types, Lidocaine segment is anticipated to contribute the largest market share in 2028.

Articaine

Articaine is a dental local anesthetic that has a rapid metabolism due to its ester group in its structure.

Bupivacaine

Bupivacaine is a local anesthetic that blocks nerve impulses in the body. Bupivacaine is injected into the spine as an epidural injection to produce a numbness during childbirth, surgery or certain medical procedures.

Lidocaine

Lidocaine is a synthetic aminoacetamide with local anesthesia and antiarrhythmic properties. Lidocaine stabilizes neuronal membranes by binding and stabilizing them.

Mepivacaine

Mepivacaine is an anesthetic that blocks nerve impulses that send pain signals to the brain. Mepivacaine is used as a local anesthetic for epidural or spinal blockers. It is also used as an anesthetic in dental surgery.

Prilocaine

Prilocaine is an amino acid amide used as a local anesthetic. It works as a local anesthetic and anticonvulsant.

Ropivacaine

Ropivacaine is an aminoamide local anesthetic that exists as a racemic mixture of enantiomers, where the enantiomers contain equal proportions of the S and R forms.

Application Overview:

By application, the Ophthalmology segment occupied the biggest share from 2018 to 2022.

Key Companies in the global Local Anesthesia Drugs market covered in Chapter 3:

Pacira Pharmaceutical
Pierrel group
Aguettant
Novartis
Sagent Pharmaceutical
Aspen Pharmacare
Mylan
Fresenius Kabi
Gedeon Richter
Gruenenthal

In Chapter 4 and Chapter 14.2, on the basis of types, the Local Anesthesia Drugs market from 2018 to 2029 is primarily split into:

Articaine
Ropivacaine
Bupivacaine
Lidocaine
Mepivacaine
Prilocaine
Other

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Local Anesthesia Drugs market from 2018 to 2029 covers:

Stomatology
Ophthalmology
Gynecology
Other

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)